Tarsus Pharmaceuticals Stock Market Value
| TARS Stock | USD 50.42 2.03 3.87% |
| Symbol | Tarsus |
Tarsus Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tarsus Pharmaceuticals. If investors know Tarsus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tarsus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.75) | Revenue Per Share 3.571 | Quarterly Revenue Growth 24.718 | Return On Assets (0.27) | Return On Equity (0.60) |
The market value of Tarsus Pharmaceuticals is measured differently than its book value, which is the value of Tarsus that is recorded on the company's balance sheet. Investors also form their own opinion of Tarsus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Tarsus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tarsus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Tarsus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tarsus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tarsus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tarsus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tarsus Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tarsus Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tarsus Pharmaceuticals.
| 12/09/2023 |
| 12/03/2024 |
If you would invest 0.00 in Tarsus Pharmaceuticals on December 9, 2023 and sell it all today you would earn a total of 0.00 from holding Tarsus Pharmaceuticals or generate 0.0% return on investment in Tarsus Pharmaceuticals over 360 days. Tarsus Pharmaceuticals is related to or competes with Aldeyra, Travere Therapeutics, Eton Pharmaceuticals, Connect Biopharma, Acumen Pharmaceuticals, Nuvation Bio, and Eledon Pharmaceuticals. Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercializati... More
Tarsus Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tarsus Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tarsus Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.37 | |||
| Information Ratio | 0.2424 | |||
| Maximum Drawdown | 16.85 | |||
| Value At Risk | (3.87) | |||
| Potential Upside | 6.32 |
Tarsus Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tarsus Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tarsus Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Tarsus Pharmaceuticals historical prices to predict the future Tarsus Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.22 | |||
| Jensen Alpha | 0.8751 | |||
| Total Risk Alpha | 0.4404 | |||
| Sortino Ratio | 0.3591 | |||
| Treynor Ratio | 1.21 |
Tarsus Pharmaceuticals Backtested Returns
Tarsus Pharmaceuticals appears to be very steady, given 3 months investment horizon. Tarsus Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.28, which indicates the firm had a 0.28% return per unit of risk over the last 3 months. By inspecting Tarsus Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.92% is justified by implied risk. Please review Tarsus Pharmaceuticals' Risk Adjusted Performance of 0.22, semi deviation of 1.89, and Coefficient Of Variation of 360.09 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tarsus Pharmaceuticals holds a performance score of 22. The entity has a beta of 0.8, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tarsus Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Tarsus Pharmaceuticals is expected to be smaller as well. Please check Tarsus Pharmaceuticals' downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to make a quick decision on whether Tarsus Pharmaceuticals' existing price patterns will revert.
Auto-correlation | 0.48 |
Average predictability
Tarsus Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Tarsus Pharmaceuticals time series from 9th of December 2023 to 6th of June 2024 and 6th of June 2024 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tarsus Pharmaceuticals price movement. The serial correlation of 0.48 indicates that about 48.0% of current Tarsus Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 61.39 |
Tarsus Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Tarsus Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tarsus Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Tarsus Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Tarsus Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tarsus Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tarsus Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tarsus Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tarsus Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Tarsus Pharmaceuticals Lagged Returns
When evaluating Tarsus Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tarsus Pharmaceuticals stock have on its future price. Tarsus Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tarsus Pharmaceuticals autocorrelation shows the relationship between Tarsus Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Tarsus Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.